Home LiteratureArticle Details
PMID: 7862124 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B.

Molecular and cellular biology ·Vol. 15 ·No. 3 ·1995-03-00 ·Pages 1302-11

DiDonato JA, Mercurio F, Karin M

Abstract

NF-kappa B is an important activator of immune and inflammatory response genes. NF-kappa B is sequestered in the cytoplasm of nonstimulated cells through interaction with the I kappa B inhibitors. These inactive complexes are dissociated in response to a variety of extracellular signals, thereby allowing free NF-kappa B dimers to translocate to the nucleus and active transcription of specific target genes. The current dogma is that phosphorylation of the I kappa Bs is responsible for dissociation of the inactive complexes, an event that is rendered irreversible by rapid I kappa B degradation. Here, we show that inducers of NF-kappa B activity stimulate the hyperphosphorylation of one of the I kappa Bs, I kappa B alpha. However, contrary to the present dogma the hyperphosphorylated form of I kappa B alpha remains associated with NF-kappa B components such as RelA (p65). Thus, phosphorylation of I kappa B alpha is not sufficient to cause dissociation of the inactive NF-kappa B:I kappa B alpha complex. However, that complex is disrupted through the selective degradation of phosphorylated I kappa B alpha in response to extracellular signals. Using a variety of protease inhibitors, some of which have specificity towards the multicatalytic proteinase complex, we demonstrate that degradation of I kappa B alpha is required for NF-kappa B activation. The results of these experiments are more consistent with a new model according to which phosphorylation of I kappa B alpha associated with NF-kappa B marks it for proteolytic degradation. I kappa B alpha is degraded while bound to NF-kappa B. The selective degradation of I kappa B alpha releases active NF-kappa B dimers which can translocate to the nucleus to activate specific target genes.

MeSH Terms
Amino Acid Sequence Carcinoma, Hepatocellular Cysteine Endopeptidases/metabolism DNA-Binding Proteins/isolation & purification,metabolism Electrophoresis, Polyacrylamide Gel HeLa Cells Humans I-kappa B Proteins Liver Neoplasms Macromolecular Substances Models, Biological Molecular Sequence Data Multienzyme Complexes/metabolism NF-KappaB Inhibitor alpha NF-kappa B/antagonists & inhibitors,isolation & purification,metabolism Oligopeptides/pharmacology Phosphorylation Protease Inhibitors/pharmacology Proteasome Endopeptidase Complex Signal Transduction Transcription Factor RelA Transfection Tumor Cells, Cultured
Chemicals
DNA-Binding Proteins I-kappa B Proteins Macromolecular Substances Multienzyme Complexes NF-kappa B NFKBIA protein, human Oligopeptides Protease Inhibitors Transcription Factor RelA NF-KappaB Inhibitor alpha Cysteine Endopeptidases Proteasome Endopeptidase Complex
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
DiDonato J A
Department of Pharmacology, University of California, San Diego School of Medicine, La Jolla 92093-0636.
Mercurio F
Karin M
References (60)
60 references, click to expand
  1. Developing selective inhibitors of calpain.
    Trends Pharmacol Sci. 1990 Apr;11(4):139-42 PMID: 2185586
  2. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
    Proc Natl Acad Sci U S A. 1992 May 15;89(10):4333-7 PMID: 1533932
  3. Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal.
    Cell. 1990 Sep 7;62(5):1019-29 PMID: 2203532
  4. Cloning of a mitogen-inducible gene encoding a kappa B DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs.
    Nature. 1990 Nov 1;348(6296):76-80 PMID: 2234062
  5. Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha.
    Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):966-70 PMID: 1992489
  6. DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.
    Cell. 1991 Mar 8;64(5):961-9 PMID: 2001591
  7. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B.
    Science. 1991 Mar 22;251(5000):1490-3 PMID: 2006423
  8. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits.
    Biochim Biophys Acta. 1991 Apr 16;1072(1):63-80 PMID: 2018779
  9. Calcium-activated neutral protease (calpain) system: structure, function, and regulation.
    Physiol Rev. 1991 Jul;71(3):813-47 PMID: 2057527
  10. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity.
    Cell. 1991 Jun 28;65(7):1281-9 PMID: 1829648
  11. The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation.
    Genes Dev. 1991 Aug;5(8):1464-76 PMID: 1907941
  12. Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.
    Nature. 1991 Aug 22;352(6337):733-6 PMID: 1876189
  13. Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex.
    Science. 1991 Aug 16;253(5021):762-8 PMID: 1876833
  14. Rel-associated pp40: an inhibitor of the rel family of transcription factors.
    Science. 1991 Sep 13;253(5025):1268-71 PMID: 1891714
  15. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates.
    Methods Enzymol. 1991;201:110-49 PMID: 1943760
  16. Generation of p50 subunit of NF-kappa B by processing of p105 through an ATP-dependent pathway.
    Nature. 1991 Dec 5;354(6352):395-8 PMID: 1956402
  17. Cytoplasmic retention, DNA binding and processing of the NF-kappa B p50 precursor are controlled by a small region in its C-terminus.
    EMBO J. 1991 Dec;10(13):4159-67 PMID: 1756723
  18. NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats.
    Trends Biochem Sci. 1992 Apr;17(4):135-40 PMID: 1533967
  19. Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex.
    Mol Cell Biol. 1992 Jun;12(6):2898-908 PMID: 1588976
  20. Antioxidant effect of diethyldithiocarbamate on microsomal lipid peroxidation assessed by low-level chemiluminescence and alkane production.
    FEBS Lett. 1983 Dec 12;164(2):371-4 PMID: 6317459
  21. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.
    Cell. 1986 Dec 26;47(6):921-8 PMID: 3096580
  22. An inducible transcription factor activates expression of human immunodeficiency virus in T cells.
    Nature. 1987 Apr 16-22;326(6114):711-3 PMID: 3031512
  23. Synthesis of a new cell penetrating calpain inhibitor (calpeptin).
    Biochem Biophys Res Commun. 1988 Jun 30;153(3):1201-8 PMID: 2839170
  24. A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon.
    Oncogene. 1989 Jul;4(7):935-42 PMID: 2666912
  25. In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C.
    Mol Cell Biol. 1989 Jun;9(6):2424-30 PMID: 2548081
  26. ATP-dependent incorporation of 20S protease into the 26S complex that degrades proteins conjugated to ubiquitin.
    Proc Natl Acad Sci U S A. 1989 Oct;86(20):7751-5 PMID: 2554287
  27. The proteasome (multicatalytic protease) is a component of the 1500-kDa proteolytic complex which degrades ubiquitin-conjugated proteins.
    J Biol Chem. 1990 Mar 25;265(9):4789-92 PMID: 2180950
  28. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.
    Nature. 1990 Apr 12;344(6267):678-82 PMID: 2157987
  29. The regulation of transcription by phosphorylation.
    Cell. 1992 Aug 7;70(3):375-87 PMID: 1643656
  30. Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105.
    DNA Cell Biol. 1992 Sep;11(7):523-37 PMID: 1388725
  31. Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex.
    Biochemistry. 1992 Oct 6;31(39):9421-8 PMID: 1356435
  32. The Rel family: models for transcriptional regulation and oncogenic transformation.
    Biochim Biophys Acta. 1992 Sep 14;1114(1):1-17 PMID: 1327144
  33. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.
    Genes Dev. 1992 Oct;6(10):1899-913 PMID: 1340770
  34. The precursor of NF-kappa B p50 has I kappa B-like functions.
    Cell. 1992 Oct 16;71(2):243-53 PMID: 1423592
  35. Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus.
    EMBO J. 1993 Jan;12(1):201-11 PMID: 7679069
  36. Modulation of cellular signals by calpain.
    Ann N Y Acad Sci. 1992 Dec 31;674:218-27 PMID: 1337690
  37. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.
    Int Rev Cytol. 1993;143:1-62 PMID: 8449662
  38. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway.
    Science. 1993 Mar 26;259(5103):1912-5 PMID: 8096091
  39. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.
    Genes Dev. 1993 Apr;7(4):705-18 PMID: 8458581
  40. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha.
    Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2532-6 PMID: 8460169
  41. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.
    Mol Cell Biol. 1993 Jun;13(6):3301-10 PMID: 8497253
  42. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells.
    J Biol Chem. 1993 Jun 5;268(16):11803-10 PMID: 8505309
  43. Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells.
    J Biol Chem. 1993 Aug 15;268(23):17489-94 PMID: 8349628
  44. NF-kappa B activation by ultraviolet light not dependent on a nuclear signal.
    Science. 1993 Sep 10;261(5127):1442-5 PMID: 8367725
  45. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B.
    Nature. 1993 Sep 9;365(6442):182-5 PMID: 8371761
  46. Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposition of iron.
    Hepatology. 1993 Oct;18(4):874-80 PMID: 8406363
  47. In vivo control of NF-kappa B activation by I kappa B alpha.
    EMBO J. 1993 Dec;12(12):4685-95 PMID: 8223478
  48. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.
    Genes Dev. 1993 Nov;7(11):2064-70 PMID: 8224838
  49. Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B.
    Nucleic Acids Res. 1993 Nov 11;21(22):5059-66 PMID: 8255759
  50. A novel cis element mediating ligand-independent activation by c-ErbA: implications for hormonal regulation.
    Cell. 1993 Dec 17;75(6):1095-105 PMID: 7903219
  51. Autoregulation of I kappa B alpha activity.
    Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):28-32 PMID: 8278379
  52. Comparison of the effect of calpain inhibitors on two extralysosomal proteinases: the multicatalytic proteinase complex and m-calpain.
    J Neurochem. 1994 May;62(5):1989-94 PMID: 8158145
  53. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
    Cell. 1994 Sep 9;78(5):773-85 PMID: 8087845
  54. Direct evidence for the presence of histidine in the active center of chymotrypsin.
    Biochemistry. 1963 Mar-Apr;2:252-5 PMID: 13992248
  55. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.
    Cell. 1991 Dec 20;67(6):1075-87 PMID: 1760839
  56. RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
    Mol Cell Biol. 1992 Feb;12(2):674-84 PMID: 1732739
  57. A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.
    Mol Cell Biol. 1992 Feb;12(2):685-95 PMID: 1531086
  58. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit.
    Cell. 1992 Mar 20;68(6):1121-33 PMID: 1547506
  59. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
    Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2489-93 PMID: 1532257
  60. The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.
    Cell. 1990 Sep 7;62(5):1007-18 PMID: 2203531
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1995-03-00
Pages
1302-11
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC230353
Subset
IM
Grants
NCI NIH HHS · CA50528 · United States
NIDDK NIH HHS · DK-085401 · United States
NHLBI NIH HHS · HL35018 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]